Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
38 (II) (12): 18304 Evans AM, Faul R, Fornasini G, et al
MCAS is fundamentally a condition of inappropriate mast cell activation with little to no neoplastic proliferation, distinguished from mastocytosis
We've worked with hundreds of researchers managing these compounds
Hematological toxicities in parp inhibitors: A real-world study using fda adverse event reporting system (Faers) database
US$ 22.83
US$ 26.45
US$ 24.25
US$ 27.66
US$ 23.10
US$ 25.57
US$ 22.73
US$ 25.30
US$ 29.76
US$ 24.30
US$ 20.12
